SARS-CoV-2 replicates efficiently in the upper airways during the prodromal stage, resulting in environmental viral shedding from patients with active COVID-19 as well as from asymptomatic individuals. There is a need to find pharmacological interventions to mitigate the spread of COVID-19. Hypothiocyanite and lactoferrin are molecules of the innate immune system with a large spectrum cidal activity. The Food and Drug Administration and the European Medicines Agency designated the hypothiocyanite and lactoferrin combination as an orphan drug. We report an in vitro study showing that micromolar concentrations of hypothiocyanite exhibit dose- and time-dependent virucidal activity against SARS-CoV-2 and that the latter is slightly enhanced by the simultaneous presence of lactoferrin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922920PMC
http://dx.doi.org/10.3390/pathogens10020233DOI Listing

Publication Analysis

Top Keywords

virucidal activity
8
hypothiocyanite lactoferrin
8
hypothiocyanite
4
hypothiocyanite hypothiocyanite/lactoferrin
4
hypothiocyanite/lactoferrin mixture
4
mixture exhibit
4
exhibit virucidal
4
activity vitro
4
vitro sars-cov-2
4
sars-cov-2 sars-cov-2
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!